@article{article, title  = {{Correction to: Cost Effectiveness of Ranibizumab vs Aflibercept vs Bevacizumab for the Treatment of Macular Oedema Due to Central Retinal Vein Occlusion: The LEAVO Study}},

 publisher = {{Springer Science and Business Media LLC}},

 url = {{https://doi.org/10.1007/s40273-021-01057-y }},

 year = {{2021}},

 month = {{9}},

 author = {{Pennington B and Alshreef A and Flight L and Metry A and Poku E and Hykin P and Sivaprasad S and Prevost AT and Vasconcelos JC and Murphy C and Kelly J et al}},

 doi = {{10.1007/s40273-021-01057-y}},

 volume = {{39}},

 journal = {{PharmacoEconomics}},

 issue = {{9}},

 pages = {{1099-1099}},

 note = {{Accessed on 2025/11/20}}}